D. H. Lee
Impact in
-
- Lung Cancer Treatments and Mutations
- Cerebrovascular and Carotid Artery Diseases
- Lung Cancer Diagnosis and Treatment
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Cerebrovascular and Carotid Artery Diseases 8
- Lung Cancer Treatments and Mutations 3
- Tracheal and airway disorders 1
-
- Intracranial Aneurysms: Treatment and Complications 4
- Vascular Malformations Diagnosis and Treatment 2
- Co-authors
- E.H. Tan (1 shared paper)Shun Lü (1 shared paper)Angela Märten (1 shared paper)Jean Fan (1 shared paper)Karl Kölbeck (1 shared paper)K. Park (1 shared paper)Michael Boyer (1 shared paper)L. Zhang (1 shared paper)
- Journals
- Annals of Oncology (4 papers)Journal of Clinical Pathology (2 papers)American Journal of Neuroradiology (2 papers)Acta Radiologica (2 papers)European Journal of Neurology (2 papers)
- Partner nations
- South KoreaUnited StatesGermany
In The Last Decade
D. H. Lee
15 papers receiving 876 citations
D. H. Lee's Hit Papers
Peers
Comparison fields: 5 of 62
- Pulmonary and Respiratory Medicine 572
- Oncology 337
- Cancer Research 82
- Neurology 57
- Hepatology 20
Countries citing papers authored by D. H. Lee
This map shows the geographic impact of D. H. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. H. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. H. Lee more than expected).
Fields of papers citing papers by D. H. Lee
This network shows the impact of papers produced by D. H. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. H. Lee. The network helps show where D. H. Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside D. H. Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial Hit paper breakdown → | 2017 | 401 |
| 2 | 2012 | 151 | |
| 3 | 2020 | 73 | |
| 4 | 2008 | 63 | |
| 5 | 2006 | 33 | |
| 6 | 2007 | 28 | |
| 7 | 2007 | 26 | |
| 8 | 2010 | 24 | |
| 9 | 2005 | 24 | |
| 10 | 2009 | 22 | |
| 11 | 2007 | 18 | |
| 12 | 2013 | 13 | |
| 13 | 2013 | 5 | |
| 14 | 2002 | 4 | |
| 15 | 2005 | 1 |
About D. H. Lee
D. H. Lee is a scholar working on Pulmonary and Respiratory Medicine, Neurology, Epidemiology, Cardiology and Cardiovascular Medicine and Oncology, having authored 15 papers that have together received 886 indexed citations. Recurring topics across this work include Cerebrovascular and Carotid Artery Diseases (8 papers), Intracranial Aneurysms: Treatment and Complications (4 papers), Lung Cancer Treatments and Mutations (3 papers), Acute Ischemic Stroke Management (3 papers), Vascular Malformations Diagnosis and Treatment (2 papers), Tracheal and airway disorders (1 paper), Cardiovascular Health and Disease Prevention (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (572 citations), Oncology (337 citations), Cancer Research (82 citations), Neurology (57 citations) and Hepatology (20 citations). D. H. Lee has collaborated with scholars based in South Korea, United States and Germany. Frequent co-authors include E.H. Tan, Shun Lü, Angela Märten, Jean Fan, Karl Kölbeck, K. Park, Michael Boyer, L. Zhang, Scott A. Laurie and Yajun Shi. Their work appears in journals such as Annals of Oncology, Journal of Clinical Pathology, American Journal of Neuroradiology, Acta Radiologica and European Journal of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.